Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban vs Warfarin in Early Postoperative Period for Bioprosthetic Valve Patients
NCT06476301Phase 4Not yet recruiting
- Sponsor
- Renji Hospital
- Start
- Aug 2024
- Primary completion
- Feb 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of rivaroxaban in thromboembolism, sponsored by Renji Hospital. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
rivaroxaban
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT06476301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06476301.